Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Protective Variants in Alzheimer’s Disease
Shea J. Andrews, Brian Fulton‐Howard, Alison Goate
Current Genetic Medicine Reports (2019) Vol. 7, Iss. 1, pp. 1-12
Open Access | Times Cited: 17

Showing 17 citing articles:

Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Mabel Seto, Rebecca L. Weiner, Logan Dumitrescu, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 98
Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
Kaden Nystuen, Shannon M. McNamee, Monica Akula, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 13
Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevity
Yakeel T. Quiroz, David Aguillón, Joseph F. Arboleda‐Velásquez, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons
Adamantios Mamais, Anwesha Sanyal, Austin Fajfer, et al.
Stem Cell Reports (2024) Vol. 19, Iss. 2, pp. 163-173
Open Access | Times Cited: 6
A comprehensive interpretable machine learning framework for mild cognitive impairment and Alzheimer’s disease diagnosis
Maria Eleftheria Vlontzou, Μαρία Αθανασίου, Kalliopi Dalakleidi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Nuclear factor I-C disrupts cellular homeostasis between autophagy and apoptosis via miR-200b-Ambra1 in neural tube defects
Wanqi Huang, Tianchu Huang, Yusi Liu, et al.
Cell Death and Disease (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity
Colleen S. Limegrover, Harry LeVine, Nicholas J. Izzo, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 4, pp. 1316-1330
Open Access | Times Cited: 21
Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.
Jens Pahnke, Pablo Bascuñana, Mirjam Brackhan, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2021) Vol. 2
Closed Access | Times Cited: 19
Genetic-based patient stratification in Alzheimer’s disease
Laura Hernández‐Lorenzo, Fernando García‐Gutiérrez, Ana Solbas-Casajús, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics
Vigneshwaran Namasivayam, Katja Stefan, Jens Pahnke, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 6490-6504
Open Access | Times Cited: 15
The study of Alzheimer's disease risk diagnosis based on natural killer cell marker genes in the multi-omics data
Xiaorong Chen, Fenggen Hu, Qingjia Chi, et al.
Journal of Alzheimer s Disease (2024)
Closed Access | Times Cited: 1
Biomarker Genes Discovery of Alzheimer’s Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia
Gao Wenliang, Wei Kong, Shuaiqun Wang, et al.
Brain Sciences (2022) Vol. 12, Iss. 9, pp. 1196-1196
Open Access | Times Cited: 6
The LRRK2 kinase substrates Rab8a and Rab10 contribute complementary but distinct disease-relevant phenotypes in human neurons
Adamantios Mamais, Anwesha Sanyal, Austin Fajfer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Neuroproteomics Chip-Based Mass Spectrometry and Other Techniques for Alzheimer’s Disease Biomarkers – Update
Alicia B. Pomilio, Arturo A. Vitale, Alberto Lazarowski
Current Pharmaceutical Design (2022) Vol. 28, Iss. 14, pp. 1124-1151
Closed Access | Times Cited: 5
Evolution of genetic testing supports precision medicine for caring Alzheimer's disease patients
Amalia C. Bruni, Livia Bernardi, Raffaele Maletta
Current Opinion in Pharmacology (2021) Vol. 60, pp. 275-280
Closed Access | Times Cited: 7
Biobank-scale characterization of Alzheimer's disease and related dementias identifies potential disease-causing variants, risk factors, and genetic modifiers across diverse ancestries
Marzieh Khani, Fulya Akçimen, Spencer Grant, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Functional regulatory variants implicate distinct transcriptional networks in dementia
Yonatan A. Cooper, Jessica E. Davis, Sriram Kosuri, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1

Scroll to top